Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/06/20
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/05/20
Eton Pharmaceuticals and Xellia Pharmaceuticals Announce Biorphen® (phenylephrine HCl) Co-Promotion AgreementGlobeNewsWire • 01/21/20
Eton Pharmaceuticals Announces Commercial Availability of Biorphen® (phenylephrine HCI) InjectionGlobeNewsWire • 12/02/19
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/15/19
Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) InjectionGlobeNewsWire • 10/22/19
Eton Pharmaceuticals to Participate in Lake Street 3rd Annual Best Ideas Growth ConferenceGlobeNewsWire • 09/03/19
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/10/19
Harrow Health, Inc. Is Quickly Taking Over The Ophthalmology Pharmaceutical MarketSeeking Alpha • 05/31/19
Eton Pharmaceuticals' (ETON) CEO Sean Brynjelsen on Q1 2019 Results - Earnings Conference CallSeeking Alpha • 05/10/19